Wuxi AppTec Co (FRA:WX8) Shares Outstanding (Basic Average): 2,925 Mil (As of Mar. 2026)


FRA:WX8 Wuxi AppTec Co Ltd FRA:WX8
97 GF Score
Price ¥15.52
GF Value ¥11.27
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Wuxi AppTec Co Shares Outstanding (Basic Average)?

Wuxi AppTec Co FRA:WX8 +6.98% 97 Shares Outstanding (Basic Average) is 2,925 Mil as of Mar. 2026. GuruFocus rates FRA:WX8 with a GF Score™ of 97/100 and a GF Value™ of ¥11.27 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Wuxi AppTec Co's average basic shares outstanding for the quarter that ended in Mar. 2026 was 2,925 Mil.


Wuxi AppTec Co  (FRA:WX8) Shares Outstanding (Basic Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.


Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Wuxi AppTec Co Shares Outstanding (Basic Average) Related Terms


Wuxi AppTec Co Shares Outstanding (Basic Average) Historical Data

* Premium members only.

The historical data trend for Wuxi AppTec Co's Shares Outstanding (Basic Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wuxi AppTec Co Shares Outstanding (Basic Average) Chart

Wuxi AppTec Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (Basic Average)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,912.66 2,928.14 2,937.84 2,881.19 2,858.30

Wuxi AppTec Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Outstanding (Basic Average) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,846.48 2,841.81 2,835.60 2,909.29 2,925.48
FRA:WX8
97GF Score
Wuxi AppTec Co Ltd FRA:WX8
Shares Outstanding (Basic Average) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Wuxi AppTec Co Shares Outstanding (Basic Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (Basic Average) of 2,925 Mil mean?
Wuxi AppTec Co (FRA:WX8) has a Shares Outstanding (Basic Average) of 2,925 Mil as of Mar. 2026. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Wuxi AppTec Co and its competitors.
Is Wuxi AppTec Co's Shares Outstanding (Basic Average) too high?
Wuxi AppTec Co's current Shares Outstanding (Basic Average) is 2,925 Mil. Overall, Wuxi AppTec Co has a GF Score™ of 97/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Wuxi AppTec Co's Shares Outstanding (Basic Average) compare to TMO and DHR?
Wuxi AppTec Co's Shares Outstanding (Basic Average) of 2,925 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (Basic Average) for a Medical Diagnostics & Research company?
A good Shares Outstanding (Basic Average) depends on the Medical Diagnostics & Research industry context. However, Shares Outstanding (Basic Average) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (Basic Average) mean?
A high Shares Outstanding (Basic Average) can signal that a stock is expensive relative to its fundamentals. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Wuxi AppTec Co and its competitors. Wuxi AppTec Co's current Shares Outstanding (Basic Average) is 2,925 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wuxi AppTec Co stock overvalued right now?
Based on GuruFocus' analysis, Wuxi AppTec Co (FRA:WX8) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥11.27, compared to a current price of ¥15.52 — trading 37.7% above its estimated fair value. The current Shares Outstanding (Basic Average) is 2,925 Mil. Wuxi AppTec Co's overall GF Score™ is 97/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (Basic Average) calculated?
Shares Outstanding (Basic Average) is calculated from a company's financial statements. For Wuxi AppTec Co (FRA:WX8), the current Shares Outstanding (Basic Average) is 2,925 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Wuxi AppTec Co (FRA:WX8) Overvalued in 2026?

Based on GuruFocus' analysis, Wuxi AppTec Co stock appears to be overvalued. The current stock price of ¥15.52 is trading 37.7% above its estimated GF Value™ of ¥11.27. GuruFocus considers Wuxi AppTec Co to be Significantly Overvalued.

Key valuation signals for FRA:WX8:

  • Shares Outstanding (Basic Average): 2,925 Mil
  • GF Value™: ¥11.27 vs. price of ¥15.52 (37.7% above fair value)
  • GF Score™: 97/100 with 4 warning signs

No single metric tells the full story. See the FRA:WX8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Wuxi AppTec Co Business Description

Address 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by PRC, Europe, and other regions.
97GF Score

Get the complete analysis for FRA:WX8

Shares Outstanding (Basic Average) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.52
Price
¥11.27
GF Value